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Progressive multifocal leukoencephalopathy (PML) is a rare disease that occurs mainly in immunocompromised 
patients. Despite the progressive nature of the disease, the changes on MRI during the disease course - which may 
help in monitoring the disease process - have seldom been reported. Here we describe a patient with polymerase- 
chain-reaction-proven  PML  examined  using  serial  diffusion-weighted  imaging  (DWI)  and  apparent-diffusion- 
coefficient mapping. Magnetic resonance spectroscopy (MRS) revealed that the demyelinating process was more 
active without significant neuronal loss at the newer and advancing edge of a lesion than in the older central part 
of the lesion. This case shows that MRI findings such as DWI and MRS may improve the diagnosis and the 
understanding of the pathophysiology of PML.
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Progressive multifocal leukoencephalopathy (PML) 
is a rare disease that occurs mainly in immunocom-
promised patients. Despite the progressive nature of 
the disease, the changes on serial diffusion-weighted 
imaging (DWI) and magnetic resonance spectroscopy 
(MRS) during the disease course - which may help 
in monitoring the disease process - have seldom been 
reported.
Here we demonstrate serial DWI and MRS findings 
of various lesion stages in a patient with polymerase 
chain reaction (PCR)-proven PML.
CASE REPORT
A 42-year-old previously healthy man presented with 
a 4-day history of nonfluent aphasia. His tendon re-
flexes, power, and coordination were normal. Routine 
laboratory investigations, including examination of 
the cerebrospinal fluid, produced normal findings. 
Brain computed tomography showed multiple low- 
density cerebral lesions. Magnetic resonance imaging 
(MRI) was performed, including DWI and apparent 
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Figure 1. ADC maps and DWI at the first and second examinations. (A) Axial DWI showed a high signal intensity at the left 
frontal and right parietal lesions. (B) Follow-up DWI performed 1 month after the first MRI showed extension of the previous 
lesion, with a high signal intensity on the medial border. ADC value was low to normal at the medial border of the lesion, 
whereas it was high in the center of the lesion.
Table 1. Metabolic ratios in normal white matter of a 
control subject and in older and newer PML lesions
Ratio Normal Older lesion Newer lesion
Cho/Cr 0.7 1.0 1.54
NAA/Cr 1.71 0.65 0.83
Lipids/Cr 0 1.3 1.56
Lactate/Cr 0 0.63 0.84
in the right parietal and left frontal white matter 
gave very high signals on T2-weighted images and 
low signals on T1-weighted images. DWI showed 
multiple high signals on bilateral subcortical areas 
(Fig. 1-A). With a provisional diagnosis of multiple 
cortical infarcts, an extensive etiological work-up 
was performed, but this was negative. The patient 
was transferred to the Department of Neurology and 
followed at an outpatient clinic.
Thirty days later the patient developed global 
aphasia and dysphasia, at which time MRI revealed 
marked progression of the cerebral lesion on both 
sides (Fig. 1-B). DWI showed extension of the 
previous lesions with diverse signals, notably with 
high signals on their medial borders. The ADC maps 
showed different regions within the lesions: the 
diffusion was normal to low at the medial border 
(0.83±0.04 mm
3/s, mean±SD) but high at the center 
(1.92±0.08 mm
3/s). Proton MRS was performed over 
the new and old lesions, and also over the normal 
brain parenchyma in healthy volunteers as a control 
(Fig. 2) since asymptomatic AIDS patients may have 
abnormalities in MRS.
1 Choline (Cho), creatine (Cr), 
N-acetylaspartate (NAA), lactate, and lipids were 
evaluated in each spectrum, and NAA/Cr, NAA/Cho, 
and Cho/Cr ratios were calculated.
Cho/Cr, lipids/Cr, and lactate/Cr ratios were higher 
and the NAA/Cr ratio was lower in both PML 
lesions than in normal control. However, the pattern 





Figure 2. Proton-MRS spectra acquired from white matter in newer (A) and older (B) PML lesions and in a control subject (C). 
Cho, lactate, and lipids were higher and NAA was lower in PML lesions than in normal white matter. Resonance values: NAA; 
2.01 ppm, Cr; 3.04 ppm, Cho; 3.22 ppm, lactate; 1.33 ppm, and lipids; 0.90 ppm.
intensity on DWI being higher, the increase in Cho 
being greater, and the decrease in NAA being 
smaller at the newer and advancing edge of a lesion 
than in the older central part of the lesion, where the 
ADC value was high (Table 1).
The diagnosis of PML was subsequently establi-
shed with positivity for serum anti-HIV antibody and 
PCR-based detection of JC virus DNA in the cerebro-
spinal fluid. The CD4 cell count was 10 cells/ml 
(normal range, 500-1000 cells/ml), and the HIV RNA 
level was 300,000 IU/ml. Highly active antiretroviral 
therapy (HAART) was initiated, and 2 months later 
the patient progressed to a bedridden state.
DISCUSSION
PML occurs mainly in immunocompromised patients, 
manifesting as a progressive decline in neurologic 
functions. However, PML should also be considered 
in the differential diagnosis of apparently healthy 
patients with focal deficits. The present case with 
PML was apparently healthy and presented with 
manifestations suggestive of a stroke, and showed a 
high signal intensity on DWI. However, the patient 
presented clinical features consistent with PML 
during the follow-up, including rapidly progressive 
neurological decline, suggesting nonvascular disease. 
DWI may be useful for evaluating or monitoring 
disease activity and for the differential diagnosis of 
patients with atypical clinical features. The DWI 
findings of patients with PML differ in asynchronous 
lesions and are dependent on the stage, as in our 
case.
2-4 Newer lesions and the advancing edges of 
large lesions had normal-to-low ADCs and gave a 
high signal on DWI, whereas the older lesions and 
the centers of the large lesions had increased ADCs 
and gave a low signal on DWI. These striking findings 
might help to differentiate PML from mimicking 
diseases, such as ischemic stroke, multiple sclerosis, 
or MELAS (mitochondrial myopathy, encephalopathy, 
lactic acidosis, and strokelike episodes), especially in Yoon JH, et al. DWI and Proton MR Spectroscopy Pattern in Progressive Multifocal Leukoencephalopathy
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young and apparently healthy patients such as the 
case reported here.
MRS has been used for histopathologic correlations in 
brain tumors, multiple sclerosis, epilepsy, and neuro-
degenerative disorders. There are reported data of homo-
geneous spectroscopic patterns in PML characterized 
by a decrease in the NAA/Cr ratio and an increase 
in the lactate/Cr, Cho/Cr, and lipids/Cr ratios relative 
tohealthy control subjects or on the contralateral side
5-7; 
however, most of these investigations did not measure 
asynchronous lesions. In our patient, the MRS pattern 
differed depending on the stage, with the Cho increase 
being greater and the NAA decrease being smaller in 
newer lesions than in older ones, suggesting the presence 
of an ongoing demyelinating process without severe 
neuronal or axonal loss. These MRS findings are in 
good agreement with previous pathologic findings 
showing ongoing demyelination with swollen oligoden-
drocytes at the border of a lesion, but sparse oligoden-
drocytes, large extracellular space, and axonal disruption 
in the center of the lesion.
8
There is increasing awareness about PML because 
the use of many immunosuppressant treatments in 
patients with multiple sclerosis and organ transplants 
may predispose them to JC virus reactivation, leading 
to PML.
9,10
This emphasizes the need for prompt diagnosis 
and monitoring of the disease process. Although we 
could not perform serial MRS studies during the 
course of HAART, MRS has the advantage of 
determining the effects of such an active treatment 
modality, as well as for evaluating the clinical course 
of patients with PML, which cannot be obtained in 
a postmortem investigation. Future studies should 
attempt to confirm these observations in more patients 
with PML.
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